This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter

Deep Track Capital bought 6,772,595 shares of Alumis last quarter, with an estimated transaction value of $169.31 million based on average prices. The filing points to meaningful institutional accumulation in the biotech name, which may be modestly supportive for sentiment. The article is otherwise factual and does not include operating results or guidance changes.

Analysis

Deep Track Capital bought 6,772,595 shares of Alumis last quarter, with an estimated transaction value of $169.31 million based on average prices. The filing points to meaningful institutional accumulation in the biotech name, which may be modestly supportive for sentiment. The article is otherwise factual and does not include operating results or guidance changes.